NBC Securities Inc. Buys 668 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

NBC Securities Inc. boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.3% during the first quarter, HoldingsChannel reports. The fund owned 7,859 shares of the company’s stock after purchasing an additional 668 shares during the quarter. NBC Securities Inc.’s holdings in Henry Schein were worth $593,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. CWM LLC grew its holdings in Henry Schein by 8.4% during the 1st quarter. CWM LLC now owns 5,822 shares of the company’s stock worth $440,000 after acquiring an additional 452 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Henry Schein by 5.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 87,085 shares of the company’s stock worth $6,593,000 after acquiring an additional 4,591 shares during the last quarter. Vanguard Group Inc. grew its holdings in Henry Schein by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 15,171,464 shares of the company’s stock worth $1,148,632,000 after acquiring an additional 161,891 shares during the last quarter. Wahed Invest LLC grew its holdings in Henry Schein by 9.2% during the 4th quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock worth $168,000 after acquiring an additional 187 shares during the last quarter. Finally, SageView Advisory Group LLC bought a new stake in Henry Schein during the 4th quarter worth approximately $285,000. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Performance

HSIC opened at $66.55 on Friday. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. The company has a market cap of $8.52 billion, a price-to-earnings ratio of 22.48, a PEG ratio of 1.68 and a beta of 0.90. The company’s fifty day moving average price is $70.52 and its two-hundred day moving average price is $73.11.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. During the same quarter in the prior year, the business posted $1.21 EPS. The business’s revenue was up 3.7% compared to the same quarter last year. On average, analysts expect that Henry Schein, Inc. will post 5.17 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HSIC. Jefferies Financial Group boosted their price target on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. Piper Sandler boosted their price target on shares of Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. Barrington Research boosted their price target on shares of Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 8th. JPMorgan Chase & Co. boosted their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. Finally, UBS Group dropped their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $81.73.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.